GCC19CART for Patients With Metastatic Colorectal Cancer

ABSTRACT: Study ICT-GCC19CART-US-001 (CARAPIA-1) is a Phase 1 study evaluating the safety, tolerability, clinical activity, pharmacokinetics and pharmacodynamics of GCC19CART in subjects with relapsed or refractory metastatic colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2718019 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR